DARZALEX is indicated for the treatment of patients:, with newly diagnosed multiple myeloma:,- who are eligible for autologous stem cell transplant. For use in combination with:,? bortezomib, thalidomide, and dexamethasone.,- who are ineligible for autologous stem cell transplant. For use in combination with:,? bortezomib, melphalan and prednisone, or,? lenalidomide and dexamethasone., with multiple myeloma who have received:,- at least one prior therapy. For use in combination with:,? bortezomib and dexamethasone, or,? lenalidomide and dexamethasone.,- at least three prior lines of therapy including a proteasome inhibitor (PI) and an
immunomodulatory agent or who are refractory to both a PI and an
immunomodulatory agent. For use as:,? monotherapy.
How to take it
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Store at 2 to 8 degrees Celsius
Do not Freeze
Protect from Light
See Product information for shelf life
Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
DARZALEX is a colourless to yellow liquid concentrate
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
DARZALEX is indicated for the treatment of patients:, with newly diagnosed multiple myeloma:,- who are eligible for autologous stem cell transplant. For use in combination with:,? bortezomib, thalidomide, and dexamethasone.,- who are ineligible for autologous stem cell transplant. For use in combination with:,? bortezomib, melphalan and prednisone, or,? lenalidomide and dexamethasone., with multiple myeloma who have received:,- at least one prior therapy. For use in combination with:,? bortezomib and dexamethasone, or,? lenalidomide and dexamethasone.,- at least three prior lines of therapy including a proteasome inhibitor (PI) and an
immunomodulatory agent or who are refractory to both a PI and an
immunomodulatory agent. For use as:,? monotherapy.
How to take it
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Store at 2 to 8 degrees Celsius
Do not Freeze
Protect from Light
See Product information for shelf life
Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
DARZALEX is a colourless to yellow liquid concentrate
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.